Thu, Dec 25, 2014, 9:19 AM EST - U.S. Markets closed for Christmas

Recent

% | $
Quotes you view appear here for quick access.

Deckers Outdoor Corp. Message Board

soozanie 10 posts  |  Last Activity: Dec 23, 2014 3:49 PM Member since: Apr 20, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • soozanie by soozanie Dec 23, 2014 3:49 PM Flag

    taking in shares here at 70.00 on a scale and very pleased. personally think the GILD news with express script resistance to cost was expected and frankly...... reasonable! INCY has a nice pipe, growing label and fantastic upside given their target markets.

    happy to let the weak length get shaken lose from the sector.

  • Reply to

    40.50 per share

    by soozanie Dec 17, 2014 3:07 PM
    soozanie soozanie Dec 18, 2014 8:53 AM Flag

    i only have 7,000 shares, but will vote against this deal. I value Pantry closer to $40-42 based on real estate holdings, gross margins and growth. i'd expect that their is the potential for another hostile bid. deal price is too low imo.

  • soozanie by soozanie Dec 17, 2014 3:07 PM Flag

    that wil be the deal price +/-. guessing the buyer is going to be from the great white north(canafa) unless you see an mlp player jump in and pay a stupid number which is always possible.

  • per INCY'S site....."Four clinical collaborations with anti-PD-1/PD-L1 immunotherapies"

    looks like Merck's data has proved that the class/approach is amazing. I'd say this greatly increases the chance that someone makes a play for INCY given that they will be cash flow positive next year and a cash machine in 2017.

    looking for $135-140 next year.

  • soozanie by soozanie Dec 4, 2014 11:41 AM Flag

    100k shares. 1) he will get more shares granted to him in january. 2) there is no way he won't be screwed on a negative fda decision tomorrow.

    overall i remain a bull. think that we can get to 80-82

  • soozanie by soozanie Nov 21, 2014 1:44 PM Flag

    just got an "alert". looks like someone just bought double the open in on the 7.00 call at .75.
    seems like the rocket ship fueling up. time will tell.

  • Reply to

    This move is super bullish !!

    by bonkenx Oct 31, 2014 1:10 PM
    soozanie soozanie Nov 2, 2014 7:35 AM Flag

    My view is longer term. I believe label expansion, new drug approvals for cancer and r.a./inflammatory disease will lead to annual revenue of 2b in 2-3 years with plenty of growth thereafter. As a result, I believe valuation with. Obviously trend much higher.

    Price target for 24 months is completely reasonable at $140 with a potential $210/220 target with positive immunotherapy results down the road. Here is the "thing"......I think it is far more likely that incy is bought out before hitting is true price potential.

    P.s. Note how bio techs generally peak out at 10b mkt cap and then it appears the next valuation range for publically traded companies is 30-40b. Said another way, if this move gets going it will be long and strong.

  • soozanie soozanie Oct 12, 2014 5:56 PM Flag

    I think you are naive to make such a statement. The antiviral is mainly used to give body a chance to produce enough antigens to slow the cascade of the viral infection. Said another way, let the body catch up to battling the virus. No doubt the blood transfusion helped(personal opinion) but your comment seems to be biased.

  • end of the quarter and short sellers marking the price as low as possible. i am loading up teh boat here for a trade back up in the 1h of oct.

  • soozanie by soozanie Sep 28, 2014 1:50 PM Flag

    I've posted before that ECYT reminds me of PCYC of ten years ago. Early bumps along the road, but a cutting edge and novel approach to treatment. ECYT hit a big bump on May 2nd and some people are still bitter and burned by that day. I've stuck with ECYT because I believe in their approach to treatment and like the data presented. Do I "buy it" ? I dunno, but I can say that it is certainly not neutral or negative. Potentially this validates the platform and ecyt can go back and try ovarian cancer for round number 2.

    I think ecyt will open around 12-13 and settle out at that level. I think plenty of money that bought in the 6-7 area will be happy to sell out for a doublet and shorts will gobble up those shares.....hence not much of a trade range after the initial gap. Overall, if we receive further validation I believe that shares will be trading $60 over time.

DECK
90.95-1.01(-1.10%)Dec 24 1:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Amira Nature Foods Ltd.
NYSEWed, Dec 24, 2014 1:04 PM EST